Clinical Trials
2 trialsNCT01916187 2020-09-21
Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma
Canadian Cancer Trials Group
Phase 1 Withdrawn
NCT01568632 2012-11-21
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn